Who Should Consider Genetic Testing?Video Categories: 2018 AONN Midyear and Video Library
Dr Andrey Antov identifies situations in which people may want to consider genetic testing.
Dr Thomas Bachelot is careful to set reasonable expectations for his patients with HR+/HER2–metastatic breast cancer regarding how long their treatment will last and how it will impact them.
Ixazomib may have the potential for great combinability with other drugs, according to Dixie-Lee Esseltine, MD and George Mulligan, PhD. Combination therapy improves compliance, adherence, and quality of life among patients.